Lady Gaga Wants People with Migraine to Know They Are Not Alone

Posted

Content sponsored and provided by Pfizer. Lady Gaga has partnered with Pfizer to share her experience with migraine and Nurtec® ODT (rimegepant), a prescription medication for the acute treatment of migraine with or without aura and the preventive treatment of episodic migraine in adults.



(NAPSI)—Lady Gaga has been living with a silent disease—migraine—for most of her life, having been diagnosed when she was 14 years old. Her migraine attacks were so severe, she was often bedridden for days. She couldn’t read or keep lights on and would have to be alone in a quiet room for hours, or sometimes even days, until the pain subsided. Lady Gaga continued to experience migraine attacks into adulthood and the disease has impacted all aspects of her life.



“By the time I was 25, I was dealing with other medical conditions along with my migraine. The combination of pain from migraines and managing these other conditions had become so difficult that I was barely functional. And the migraines were now much more present. The hardest part about dealing with this change in my life is that it was now not once a month that I was getting migraines, but much more frequently.”



This is the first time Lady Gaga has spoken about her experience with migraine, and she hopes that sharing her story will help empower others to be more vocal about their migraine pain. Migraine, which affects nearly 40 million Americans, is considered the second-most disabling condition worldwide.1,2



Lady Gaga spoke to her doctor and began taking Nurtec® ODT (rimegepant) as an acute treatment for migraine. “I’m so grateful to my family, friends and fans for going on this journey with me throughout the years so I can share my story and hopefully it will help more people find the relief they need,” said Lady Gaga. You can learn more about Lady Gaga’s migraine story and Nurtec ODT at nurtec.com/ladygaga.


WHAT IS NURTEC ODT?



Nurtec ODT orally disintegrating tablets is a prescription medicine that is used to treat migraine in adults. It is for the acute treatment of migraine attacks with or without aura and the preventive treatment of episodic migraine. It is not known if Nurtec ODT is safe and effective in children.



IMPORTANT SAFETY INFORMATION


Do not take Nurtec ODT if you are allergic to Nurtec ODT (rimegepant) or any of its ingredients.



Before you take Nurtec ODT, tell your healthcare provider (HCP) about all your medical conditions, including if you:

• have liver problems,

• have kidney problems,

• are pregnant or plan to become pregnant,

• are breastfeeding or plan to breastfeed.



Tell your HCP about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.



Nurtec ODT may cause serious side effects including allergic reactions, including trouble breathing and rash. This can happen days after you take Nurtec ODT. Call your HCP or get emergency help right away if you have swelling of the face, mouth, tongue, or throat or trouble breathing. This occurred in less than 1% of patients treated with Nurtec ODT.



The most common side effects of Nurtec ODT were nausea (2.7%) and stomach pain/indigestion (2.4%). These are not the only possible side effects of Nurtec ODT. Tell your HCP if you have any side effects.



You are encouraged to report side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088 or report side effects to Pfizer at 1-833-4Nurtec.



See full Prescribing Information and Patient Information.



1. Buse et al. Burden of Illness Among People with Migraine and ? 4 Monthly Headache Days While Using Acute and/or Preventive Prescription Medications for Migraine. Journal of Managed Care & Specialty Pharmacy. 2020;26(10):1334-1343.

2. GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2018;17(11):954-976.

PP-NNT-USA-2559